• Article

Risk of Autoimmune Diseases (AD) After Human Papillomavirus (HPV)-16/18 AS04-Adjuvanted Vaccine Immunization in Women Aged 9 to 25 Years in the United Kingdom

Citation

Willame, C., Rosillon, D., Zima, J., Angelo, M. G., Stuurman, A., Vroling, H., ... Baril, L. (2015). Risk of Autoimmune Diseases (AD) After Human Papillomavirus (HPV)-16/18 AS04-Adjuvanted Vaccine Immunization in Women Aged 9 to 25 Years in the United Kingdom: An Observational Cohort Study (Meeting Abstract 717). Pharmacoepidemiology and Drug Safety, 24(Supplement: 1), 409-409.